Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010639 |
---|---|
Receipt number | R000012444 |
Scientific Title | Phase I study of TS-1+irinotecan+cetuximab as the first-line therapy in patients with KRAS wild-type metastatic colorectal cancer |
Date of disclosure of the study information | 2013/05/07 |
Last modified on | 2019/03/08 09:58:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/05/03 08:27:35 | ||
2 | Update | 2013/11/03 09:34:01 | TEL |
|
3 | Update | 2014/05/03 11:28:50 | Recruitment status |
|
4 | Update | 2016/05/03 09:37:52 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/11/15 13:26:29 | Key inclusion criteria |
|
6 | Update | 2016/11/15 13:27:45 | Publication of results |
|
7 | Update | 2019/03/08 09:58:11 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |